Coronavirus | Haffkine Bio-Pharma targets 22.8 crore Covaxin vials a year
The Hindu
It will be at least a year before the company begins actual production.
After receiving permission to make Bharat Biotech's COVID-19 vaccine Covaxin, Mumbai-based Haffkine Bio-Pharmaceutical on Friday said it would take at least a year for the company to start actual production. A top official said the state-run company is targeting to produce 22.8 crore vials of the vaccine per year. Speaking to reporters in Mumbai, Dr Sandeep Rathod, managing director, Haffkine Bio-Pharmaceutical Corporation Ltd, said, “Our target is to produce around 22.8 crore vaccine vials but it will take one year for us to start production.” Hyderabad-based Bharat Biotech and the ICMR have developed Covaxin, one of the two vaccines being used in the ongoing nationwide COVID-19 vaccination drive.More Related News